180 Life Sciences CORP Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
Zippy, Inc. has disclosed beneficial ownership of 571,427 shares, representing 4.3% of Forum Markets Inc.'s common stock, as of April 20, 2026.
Brian James Pemble has amended his Schedule 13G filing to report beneficial ownership of 1,451,714 shares of Forum Markets, Incorporated common stock, representing 10.99% of the class.
Hudson Bay Capital Management LP and Sander Gerber have disclosed a 1.84% beneficial ownership stake in ETHZilla Corp, primarily through call options.
SCHEDULE 13G: Zippy Inc. Takes 7.1% Stake in ETHZilla Corp
Zippy Inc. has disclosed a 7.1% beneficial ownership stake in ETHZilla Corp, holding 1,333,332 shares of common stock.
Brian Pemble has reported a beneficial ownership of 6.91% of ETHZilla Corp's common stock.
SCHEDULE 13G/A: Steadfast Capital Discloses 4.5% Stake in ETHZilla Corp
Steadfast Capital Management LP and its affiliates have reported a passive 4.5% beneficial ownership stake in ETHZilla Corp's common stock as of September 30, 2025.
Peter Thiel and affiliated entities have disclosed their beneficial ownership in ETHZilla Corporation, totaling 5.6% of common stock after a 1-for-10 reverse stock split.
Hudson Bay Capital Management LP and Sander Gerber have reported a 9.99% beneficial ownership stake in ETHZilla Corp, primarily through convertible notes.
Brian Pemble has reported a beneficial ownership of 5.1% of ETHZilla Corp's common stock as an individual investor.
Electric Capital Partners Frontier Master Fund and its affiliates have disclosed a significant 8.6% beneficial ownership stake in ETHZilla Corporation.
Cyber Citadel and Konstantin Lomashuk report beneficial ownership of 9.99% of ETHZilla Corporation's common stock.
Citadel entities and Kenneth Griffin have disclosed beneficial ownership of 8,418,198 shares, representing a 5.3% stake in ETHZilla Corporation.
Steadfast Capital Management LP and its affiliates reported a passive beneficial ownership of 7.3% in 180 Life Sciences Corp.'s common stock.
Peter Thiel and affiliated entities have disclosed a beneficial ownership of 7.5% in 180 Life Sciences Corp., totaling 11,592,241 common shares.
AmTrust Financial Services, Inc. and its subsidiary AmTrust International Underwriters DAC have reported zero beneficial ownership in 180 Life Sciences Corp. common stock as of July 17, 2025.
Anson Funds Management LP and its affiliated entities have filed an amendment to disclose a 4.5% beneficial ownership stake in 180 Life Sciences Corp., held for ordinary business purposes.
Ayrton Capital LLC and Alto Opportunity Master Fund, along with Waqas Khatri, have disclosed a passive 4.55% beneficial ownership stake in 180 Life Sciences Corp. through warrants.
AmTrust Financial Services, Inc. and its subsidiary AmTrust International Underwriters DAC have disclosed a passive 9.8% beneficial ownership stake in 180 Life Sciences Corp.
Anson Funds Management LP and its affiliates, including key individuals, have disclosed a beneficial ownership of 7.1% in 180 Life Sciences Corp., totaling 225,271 shares of common stock.
Ayrton Capital LLC, Alto Opportunity Master Fund, SPC Segregated Master Portfolio B, and Waqas Khatri have jointly disclosed a 9.9% beneficial ownership stake in 180 Life Sciences Corp. as of December 31, 2024.
SCHEDULE 13G: Intracoastal Capital and Affiliates Disclose 4.99% Passive Stake in 180 Life Sciences Corp.
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has disclosed a passive beneficial ownership of 4.99% of 180 Life Sciences Corp.'s common stock as of January 3, 2025.